When E-Cadherin Becomes Unstuck in Cancer

N Engl J Med. 2020 Aug 27;383(9):871-873. doi: 10.1056/NEJMcibr2018713.

Author

Lorraine O'Driscoll¹

Affiliation

¹ From the School of Pharmacy and Pharmaceutical Sciences and Trinity Biomedical Sciences Institute and Trinity St. James's Cancer Institute, Trinity College Dublin, Dublin.

PMID: 32846069
DOI: 10.1056/NEJMcibr2018713

No abstract available

MeSH terms

Animals
Antigens, CD / metabolism*
Antineoplastic Agents, Immunological / therapeutic use
Breast Neoplasms / drug therapy
Breast Neoplasms / metabolism*
Breast Neoplasms / pathology
Cadherins / antagonists & inhibitors
Cadherins / metabolism*
Disease Models, Animal
Epithelial-Mesenchymal Transition
Female
Humans
Mice
Neoplasm Invasiveness
Neoplasm Metastasis / drug therapy
Neoplastic Processes

Substances

Antigens, CD
Antineoplastic Agents, Immunological
CDH1 protein, human
Cadherins